BioCentury on BioBusiness,
Product Discovery & Development
First-year accomplishments of TransCelerate, pharma's precompetitive consortium
Related tables, figures and sidebars
TransCelerate up to speed
Monday, October 21, 2013
In its first year, the industry's precompetitive experiment TransCelerate
BioPharma Inc. has hit key milestones in all five of its initial projects
aimed at improving the speed and quality of clinical trials. The biopharma
consortium also has increased its membership to 18 companies from 10, and could
announce its next set of projects this year.
TransCelerate was founded last
year after a group of pharma R&D heads concluded that precompetitive
collaboration was best way to solve clinical trial bottlenecks. The hope was
that the resulting efficiencies would speed up drug development and lower costs
for all members.
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]